Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring

被引:0
|
作者
Wolpert, Howard [1 ]
Rodbard, David [2 ]
Xue, Jie [3 ]
Johnson, Jennal [3 ]
Dassau, Eyal [3 ]
机构
[1] Boston Med Ctr, Boston, MA USA
[2] Biomed Informat Consultants LLC, Potomac, MD USA
[3] Eli Lilly & Co, Indianapolis, IN USA
关键词
continuous glucose monitoring (CGM); glycaemic control; hypoglycaemia; insulin therapy; observational study; INTERNATIONAL CONSENSUS;
D O I
10.1111/dom.16249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Connected insulin pens (CIPs) provide insulin dosing data that can be leveraged to drive improvements in glycaemic control. To realize this potential in routine care, insulin data need to be distilled into actionable insights for clinicians. We describe two algorithms for detecting glucose excursions using continuous glucose monitoring (CGM) data and then link excursions to CIP data to derive "insulin metrics" characterizing suboptimal bolus dosing practices. Materials and Methods: This post hoc analysis used CGM and CIP data from a 12-week observational study (: NCT03368807) of 64 adults with type 1 or type 2 diabetes receiving multiple daily injection insulin therapy and glycated haemoglobin >= 8%. Two updated algorithms were applied to analyse glucose excursions associated with pre-meal boluses, missed bolus doses (MBDs), delayed boluses and correction boluses. Results: Glycaemic metrics obtained using both algorithms were similar. Time in range (%TIR) was lower, and time above range (%TAR) and glycaemic variability (%GV) were higher, on days with MBDs. Compared with pre-meal boluses, delayed and correction boluses were followed by glucose excursions with larger change in glucose, longer duration with glucose >180 mg/dL, lower post-excursion %TIR and higher post-excursion %TAR; excursions following MBDs showed lower %TIR, higher %TAR and lower percent recovery. Glucose excursions were larger and longer when CGM was masked than when unmasked. Conclusions: This analysis demonstrates "insulin metrics"-characterizations of insulin dosing behaviour derived from integrated CGM and CIP data-and provides a foundation for future work that will expand the understanding of an individual's insulin self-administration practices and improve clinical decision-making.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Assessing glycaemic excursions by continuous glucose monitoring system (CGMS) in patients with type 2 diabetes treated with insulin secretagogues
    Li, Y.
    Xu, L.
    Shen, J.
    Ran, J.
    Zhang, Y.
    Wang, M.
    Yan, L.
    Fu, Z.
    DIABETOLOGIA, 2008, 51 : S13 - S13
  • [2] Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles
    Bergenstal, Richard M.
    Johnson, Mary L.
    Aroda, Vanita R.
    Brazg, Ronald L.
    Dreon, Darlene M.
    Frias, Juan P.
    Kruger, Davida F.
    Molitch, Mark E.
    Mullen, Deborah M.
    Peyrot, Mark
    Richter, Sara
    Rosenstock, Julio
    Serusclat, Pierre
    Vance, Carl
    Weinstock, Ruth S.
    Levy, Brian L.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (05): : 1167 - 1173
  • [3] Comparing patch vs pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles
    Johnson, M. L.
    Dreon, D. M.
    Levy, B. L.
    Richter, S.
    Mullen, D.
    Bergenstal, R. M.
    DIABETOLOGIA, 2018, 61 : S395 - S395
  • [4] A Telehealth Program Using Continuous Glucose Monitoring and a Connected Insulin Pen Cap in Nursing Homes for Older Adults with Insulin-Treated Diabetes: The Trescasas Study
    Gomez-Peralta, Fernando
    Abreu, Cristina
    Santos, Estefania
    Da Silva, Alvaro
    San Frutos, Ana
    Vega-Valderrama, Luisa
    Garcia-Galindo, Marta
    Franco-Lopez, Ana
    Mardomingo, Cristina Lopez
    Canuelo, Benito
    Blazquez, Guillermo
    Matabuena, Marcos
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024,
  • [5] Standardizing Reporting of Glucose and Insulin Data for Patients on Multiple Daily Injections Using Connected Insulin Pens and Continuous Glucose Monitoring
    Rodbard, David
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (03) : 221 - 226
  • [6] Comparing Patch vs. Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles
    Johnson, Mary L.
    Dreon, Darlene M.
    Levy, Brian L.
    Richter, Sara
    Mullen, Deborah
    Bergenstal, Richard M.
    DIABETES, 2018, 67
  • [7] Efficacy and Feasibility of a Telemedicine Program for Institutionalized Elderly People with Insulin-Treated Diabetes Using Continuous Glucose Monitoring and a Connected Insulin Pen Cap-The Trescasas Study
    Gomez-Peralta, Fernando
    Abreu, Cristina
    Mazo, Estefania S.
    DIABETES, 2024, 73
  • [8] Development of application to automatically calculate mean amplitude of glycaemic excursions using intermittently scanned continuous glucose monitoring data
    Kitae, Aya
    Kimura, Tetsuya
    Munekawa, Chihiro
    Hosomi, Yukako
    Osaka, Takafumi
    Kitagawa, Noriyuki
    Ushigome, Emi
    Yamazaki, Masahiro
    Hamaguchi, Masahide
    Fukui, Michiaki
    DIABETES OBESITY & METABOLISM, 2021, 23 (09): : 2155 - 2160
  • [9] Glycaemic profile by continuous glucose monitoring system in a cohort of adolescents treated with continuous subcutaneous insulin infusion or long acting insulin analogues
    Anzellotti, M.
    Di Stefano, A.
    Carinci, S.
    Chiarelli, F.
    Tumini, S.
    DIABETOLOGIA, 2008, 51 : S438 - S438
  • [10] SMART BOLUS CALCULATOR FOR PERSONALIZED INSULIN DOSING USING CONTINUOUS GLUCOSE MONITORING DATA AND PATIENT CHARACTERISTICS
    Cappon, G.
    Vettoretti, M.
    Facchinetti, A.
    Sparacino, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A16 - A17